The Rise of CancerTech Startups

These startups often use advanced technologies like artificial intelligence, genomics, or new drug delivery methods. According to the European Patent Office (EPO), there are around 1,500 cancer tech startups in Europe.

Let's Explore the list of Top Cancertech startup In Europe

Kuano

Founded in 2017, Kuano uses advanced simulation and AI to bring quantum-level detail to structure-based drug discovery. By combining expertise in drug development and technology, they explore new areas of chemical space, helping design next-generation medicines.

Antiverse

Antiverse is a Welsh techbio company that specializes in designing antibodies for difficult drug targets like GPCRs and ion channels. Based in Cardiff, UK, with an office in Boston, MA, they use cutting-edge machine learning and advanced cell line engineering to develop new antibody treatments.

Awell

Awell is a CareOps platform designed for a fast-paced, adaptable world. Powered by AI, it connects care teams, systems, and workflows into one streamlined engine, making every process a learning system.

With Awell, healthcare organizations can design, deploy, and improve care delivery quickly and accurately, without needing IT help. From integrating patient data to automating care flows, Awell helps organizations move fast, stay compliant, and achieve better results by learning and improving more efficiently.

Careology

Founded in 2018 by Paul Landau, Careology changes the way cancer care is delivered. It gives healthcare professionals real-time health data and remote monitoring insights to help them provide proactive support.

CliniNote

CliniNote is a health-tech company founded in 2020, aiming to improve clinical data management. It focuses on fixing problems in collecting, processing, and using clinical data to enhance healthcare outcomes with advanced technology.

DeepLife

DeepLife is a biotech company focused on curing diseases by using Digital Twins of cells. They develop new methods based on advanced multi-omics data, AI, and systems engineering to find the molecular triggers that can return diseased cells to their healthy state.

Concr

Concr is a techbio company that uses statistical learning and advanced modeling, inspired by astrophysics, to help provide precision treatments for cancer patients.

Panakeia

Panakeia provides an AI platform that simplifies and speeds up diagnostics to help guide precise cancer treatment.

PreComb

PreComb, along with its clinical partners, offers a unique opportunity to test new drugs and drug combinations on tumor twins created from human tumor tissue. This helps evaluate the clinical effectiveness of the treatments.

Sonrai Analytics

Sonrai is the only cloud-based AI solution designed for precision medicine. Their team has created a Bioinformatics Cloud product specifically made to handle precision medicine data, solve challenges, and support success from early discovery to clinical stages and beyond.

Ignota Labs

Their AI model, SAFEPATH, uses deep learning to analyze bioinformatics and cheminformatics data to address drug safety issues. SAFEPATH applies the latest deep learning techniques to identify the cause of toxicity, predict its effects on the human body, and balance it with the drug's effectiveness.

Sycai Medical

Sycai Medical has developed an assistant that detects pre-cancerous lesions while they are still benign. It helps radiologists track the lesions by comparing new images with previous ones to show how they’ve changed.

The assistant analyzes CT scans for incidental findings with no clicks needed, fully integrated into the radiologist’s workflow without requiring any manual input.

Alvie Health

Alvie 360 is a health coaching program that lasts up to 10 weeks. It uses real data and regular coach check-ins to create a detailed, personalized health profile, covering both physical and psychological aspects. This approach helps identify and manage health risks early, tailor coaching recommendations, provide ongoing support and motivation, track progress safely, and offer expert clinical help when needed.

Receptor.AI

Receptor.AI is a next-gen TechBio company changing drug discovery with an AI-powered platform. It specializes in designing small molecules, peptides, and drug conjugates to speed up the development of new therapies for tough targets.

Their platform uses advanced technologies like the AI-docking model ArtiDock, a proprietary PPI prediction model better than AlphaFold-Multimer, and many AI models tested and tailored for specific drug design needs.